Cargando…
Prolonged survival in patients with hand-foot skin reaction secondary to cooperative sorafenib treatment
BACKGROUND: Sorafenib is an oral drug that prolongs overall survival (OS) in patients with hepatocellular carcinoma. Adverse events, including hand-foot skin reaction (HFSR), lead to permanent sorafenib discontinuation. AIM: To clarify the association between interventions for adverse events and pat...
Autores principales: | Ochi, Masanori, Kamoshida, Toshiro, Araki, Masahiro, Ikegami, Tadashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409165/ https://www.ncbi.nlm.nih.gov/pubmed/34539142 http://dx.doi.org/10.3748/wjg.v27.i32.5424 |
Ejemplares similares
-
Grade III hand-foot skin reaction induced by sorafenib
por: Chiriac, Anca, et al.
Publicado: (2017) -
Sorafenib Induced Hand-Foot Skin Reaction at Low Dose
por: Shah, Vrutika H., et al.
Publicado: (2020) -
Early colonoscopy and urgent contrast enhanced computed tomography for colonic diverticular bleeding reduces risk of rebleeding
por: Ochi, Masanori, et al.
Publicado: (2021) -
Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenib
por: Dranitsaris, G., et al.
Publicado: (2012) -
High total Joule heat increases the risk of post-endoscopic submucosal dissection electrocoagulation syndrome after colorectal endoscopic submucosal dissection
por: Ochi, Masanori, et al.
Publicado: (2021)